Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
DSS Inc (DSS)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
08/14/2025: DSS (1-star) is a SELL. SELL since 2 days. Profits (-26.96%). Updated daily EoD!
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
1 Analysts rated it
Very few follow this stock; limited insights, higher-risk early investing.
1 Year Target Price $27.6
1 Year Target Price $27.6
| 1 | Strong Buy |
| 0 | Buy |
| 0 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -48.25% | Avg. Invested days 20 | Today’s Advisory SELL |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 08/14/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 7.56M USD | Price to earnings Ratio - | 1Y Target Price 27.6 |
Price to earnings Ratio - | 1Y Target Price 27.6 | ||
Volume (30-day avg) 1 | Beta 1.35 | 52 Weeks Range 0.72 - 1.50 | Updated Date 08/15/2025 |
52 Weeks Range 0.72 - 1.50 | Updated Date 08/15/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) -6.6 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin -235.88% | Operating Margin (TTM) -75.21% |
Management Effectiveness
Return on Assets (TTM) -23.37% | Return on Equity (TTM) -99.87% |
Valuation
Trailing PE - | Forward PE - | Enterprise Value 52765701 | Price to Sales(TTM) 0.37 |
Enterprise Value 52765701 | Price to Sales(TTM) 0.37 | ||
Enterprise Value to Revenue 2.61 | Enterprise Value to EBITDA -1.9 | Shares Outstanding 9092520 | Shares Floating 2877964 |
Shares Outstanding 9092520 | Shares Floating 2877964 | ||
Percent Insiders 57.35 | Percent Institutions 1.82 |
Upturn AI SWOT
DSS Inc
Company Overview
History and Background
DSS Inc. (formerly Document Security Systems, Inc.) was founded in 1995. It initially focused on anti-counterfeiting and authentication technologies. Over time, it diversified into other sectors through acquisitions and strategic partnerships.
Core Business Areas
- Direct Marketing: Providing direct marketing solutions and services.
- Premier Packaging: Offers sustainable and premium packaging solutions, including flexible packaging, folding cartons, and specialty products.
- Digital Transformation and FinTech: Focuses on secure data, digital payment methods, and technology-based solutions for business operations and regulatory compliance.
- Healthcare: Develops and markets medical devices and provides healthcare services.
Leadership and Structure
Robert Berman serves as CEO. The company has a board of directors and operates through various subsidiaries.
Top Products and Market Share
Key Offerings
- Premier Packaging Solutions: Sustainable and premium packaging solutions that includes flexible packaging, folding cartons, and specialty products. Market share is not precisely known, but competes with companies like WestRock (WRK) and International Paper (IP).
- Impact EMV Payment Technology: EMV payment technology and platforms. This competes with Block (SQ) and PayPal (PYPL).
- Healthcare Solutions: Medical devices and healthcare service offerings. Competes with names such as Teladoc (TDOC) and DexCom (DXCM) in different areas.
Market Dynamics
Industry Overview
DSS operates in diverse industries, including packaging, direct marketing, healthcare, and digital payment/fintech. These sectors are characterized by constant innovation, stringent regulatory requirements, and intense competition.
Positioning
DSS Inc. is positioned as a diversified holding company seeking growth through acquisitions, partnerships, and internal development. Its competitive advantages depend on the performance and synergies within its subsidiaries.
Total Addressable Market (TAM)
The TAM across DSS's diverse segments is substantial, encompassing billions of dollars. Its positioning is varied across each segment, from niche player to more established in packaging, but still significantly smaller than industry leaders.
Upturn SWOT Analysis
Strengths
- Diversified business model
- Proprietary technologies (e.g., authentication)
- Acquisition-based growth strategy
- Experienced management team
Weaknesses
- Complex organizational structure
- Relatively small market share in some segments
- Dependence on acquisitions for growth
- History of inconsistent profitability
Opportunities
- Expansion into high-growth sectors
- Strategic partnerships
- Increased demand for authentication technologies
- Growing market for sustainable packaging
Threats
- Intense competition
- Economic downturns affecting various sectors
- Technological obsolescence
- Regulatory changes
Competitors and Market Share
Key Competitors
- WRK
- IP
- SQ
- PYPL
- TDOC
- DXCM
Competitive Landscape
DSS faces intense competition from larger, more established players in each of its segments. Its ability to innovate and execute its acquisition strategy is crucial for maintaining a competitive edge.
Major Acquisitions
Impact Biomedical
- Year: 2020
- Acquisition Price (USD millions): 4.2
- Strategic Rationale: To expand DSS's reach into the healthcare sector and leverage Impact Biomedical's technologies.
Growth Trajectory and Initiatives
Historical Growth: DSS's growth has been driven by acquisitions and strategic investments.
Future Projections: Future growth prospects depend on the success of acquired entities and expansion initiatives. Analyst estimates are not readily available for DSS due to its size and diversification.
Recent Initiatives: Recent initiatives include expanding its sustainable packaging segment and advancing its digital payment technologies.
Summary
DSS Inc. is a highly diversified company that focuses on multiple areas such as packaging, healthcare and payments. The company has been growing by acquisitions, and its success will depend on the proper and efficient integration of those acquisitions and the synergies that will result between the business. The main weaknesses are the difficulty of managing such different business segments and the need to improve financial performance overall. DSS needs to be watchful over its competitors and economic downturns which could affect its growth and performance.
Peer Comparison
Sources and Disclaimers
Data Sources:
- Company Website
- SEC Filings
- Market Reports
- Third-party financial data providers
Disclaimers:
This analysis is based on publicly available information and is not financial advice. Market data and figures may be approximate. Market share percentages are estimates and can vary.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About DSS Inc
Exchange NYSE MKT | Headquaters West Henrietta, NY, United States | ||
IPO Launch date 1997-01-03 | Interim CEO & COO Mr. Jason T. Grady | ||
Sector Consumer Cyclical | Industry Packaging & Containers | Full time employees 100 | Website https://www.dssworld.com |
Full time employees 100 | Website https://www.dssworld.com | ||
DSS, Inc. operates in the product packaging, biotechnology, commercial lending, securities and investment management, and direct marketing businesses in the United States. The company manufactures, markets, and sells mailers, photo sleeves, custom folding cartons, and 3-dimensional direct mail solutions; and markets and distributes nutritional and personal care products. It also invests in or acquires companies in the biohealth and biomedical fields, including businesses that focuses on the advancement of drug discovery and prevention, inhibition, and treatment of neurological, oncological, and immune related diseases; and develops open-air defense initiatives for air-borne infectious diseases comprising tuberculosis and influenza. In addition, the company focuses on acquiring equity positions in undervalued commercial banks, bank holding companies, and nonbanking licensed financial companies; and companies engages in nonbanking activities related to banking, such as loan syndication, mortgage banking, trust and escrow, banking technology, loan servicing, equipment leasing, problem asset management, special purpose acquisition company consulting, and advisory capital raising services. Further, the company provides securities and investment management services; and operates a real estate investment trust for acquiring hospitals and other acute or post-acute care centers. Additionally, it develops and/or acquires assets and investments in the securities trading and/or funds management arena, as well as lists and operates as a digital asset on secondary market. The company was formerly known as Document Security Systems, Inc. and changed its name to DSS, Inc. in September 2021. DSS, Inc. was incorporated in 1984 and is headquartered in West Henrietta, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.